Recombinant Human Orosomucoid 2 (ORM2) protein (Gln19-Ser201) [His-Tag], E. coli (CAT#: GP01-104J)

Product Overview	Recombinant Human Orosomucoid 2 (ORM2) protein (NP_000599.1) (Gln19-Ser201) was expressed in E. coli with a His-Tag at the N-terminus. The biological activity was determined by its binding ability in a functional ELISA. This product can be used in ELISA, WB, IP.
Biological Activity	Determined by its binding ability in a functional ELISA.
Source	E. coli
Species	Human
Fragment	Gln19-Ser201
Sequence	MGHHHHHHSGSEFQIPLCANLVPVPITNATLDRITGKWFYIASAFRNEEYNKSVQEIQATFFYFTPNKTEDTIFLREYQTRQNQCFYNSSYLNVQRENGTVSRYEGGREHVAHLLFLRDTKTLMFGSYLDDEKNWGLSFYADKPETTKEQLGEFYEALDCLCIPRSDVMYTDWKKDKCEPLEKQHEKERKQEEGES
Tag	His-Tag at the N-terminus
Predicted MW	23.2 KDa
Purity	>95%, determined by SDS-PAGE and HPLC
Endotoxin Level	<1 EU/μg, determined by the LAL method
Conjugation	Unconjugated

Target	ORM2
Full Name	Orosomucoid 2
Gene ID	5005
Uniprot ID	P19652
Accession Number	NP_000599.1
Background	This gene encodes a key acute phase plasma protein. Because of its increase due to acute inflammation, this protein is classified as an acute-phase reactant. The specific function of this protein has not yet been determined; however, it may be involved in aspects of immunosuppression.
Alternate Names	AGP2; AGP-B; AGP-B'; ORM2; Orosomucoid 2